Sexual hormones, cardiac mast cells and cardioprotection

性激素、心脏肥大细胞和心脏保护

基本信息

项目摘要

DESCRIPTION (provided by applicant): While cardiovascular disease is the leading cause of death in both men and women in the United States, it is only after menopause that the risk of developing congestive heart failure dramatically increases in women. The proposed study will investigate gender-specific differences in myocardial remodeling and the development of heart failure secondary to chronic volume overload. Specifically, the focus of this proposal will be estrogen's modulation of TNF-alpha production and release from cardiac mast cells. The overall hypothesis to be examined is that estrogen modulation of TNF-alpha is responsible for the gender differences in cardiovascular remodeling induced by chronic volume overload. To this end, the following specific aims will be addressed using a variety of physiological, biochemical, morphological and molecular techniques to delineate the mechanisms responsible for the gender-specific differences in cardiovascular function and the temporal progression of adverse ventricular remodeling induced secondary to either infrarenal aortocaval fistula or TNF-alpha infusion in rats. Aim 1: Does estrogen alter the dynamic remodeling process induced by chronic volume overload? Aim 2: What role does the estrogen modulation of TNF-alpha play in myocardial remodeling and development of heart failure? Aim 3: Is estrogen modulation of mast cell-derived TNF-alpha the mechanism responsible for cardioprotection observed in intact females? In summary, the proposed studies will provide a well integrated approach designed to fill a void in our understanding of the mechanisms responsible for the cardioprotection observed in premenopausal females. We have every expectation that the investigations will significantly increase our understanding of the important interactions between estrogen, cardiac mast cell-derived TNF-alpha, cardiac fibroblasts, myocytes, and the extracellular matrix during cardiovascular remodeling secondary to chronic volume overload and advance the development of novel therapeutic approaches for the prevention of heart failure.
描述(由申请人提供):虽然心血管疾病是美国男性和女性死亡的主要原因,但只有在绝经后,女性发生充血性心力衰竭的风险才会急剧增加。这项拟议的研究将调查心肌重构和慢性容量过载继发心力衰竭的性别差异。具体来说,本提案的重点将是雌激素对心脏肥大细胞中tnf - α产生和释放的调节。要检验的总体假设是,雌激素对tnf - α的调节是慢性容量过载引起的心血管重构的性别差异的原因。为此,以下具体目标将利用各种生理、生化、形态学和分子技术来描述大鼠肾下主动脉腔瘘或tnf - α输注引起的心血管功能的性别差异和不良心室重构的时间进展的机制。目的1:雌激素是否改变慢性容量过载诱导的动态重塑过程?目的2:雌激素对tnf - α的调节在心肌重塑和心力衰竭的发展中起什么作用?目的3:雌激素对肥大细胞来源的tnf - α的调节是在完整女性中观察到的心脏保护机制吗?总之,拟议的研究将提供一个很好的综合方法,旨在填补我们对绝经前女性观察到的心脏保护机制的理解空白。我们期望这项研究将显著增加我们对雌激素、心肌肥大细胞衍生的tnf - α、心脏成纤维细胞、肌细胞和细胞外基质在慢性容量过载引起的心血管重塑过程中的重要相互作用的理解,并促进预防心力衰竭的新治疗方法的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph S Janicki其他文献

Joseph S Janicki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph S Janicki', 18)}}的其他基金

Development of a Long-term, Working Cardiovascular Tissue Slice Culture
长期有效的心血管组织切片培养的发展
  • 批准号:
    8067879
  • 财政年份:
    2010
  • 资助金额:
    $ 35.4万
  • 项目类别:
Development of a Long-term, Working Cardiovascular Tissue Slice Culture
长期有效的心血管组织切片培养的发展
  • 批准号:
    7897172
  • 财政年份:
    2010
  • 资助金额:
    $ 35.4万
  • 项目类别:
Sexual hormones, cardiac mast cells and cardioprotection
性激素、心脏肥大细胞和心脏保护
  • 批准号:
    6912610
  • 财政年份:
    2004
  • 资助金额:
    $ 35.4万
  • 项目类别:
Sexual hormones, cardiac mast cells and cardioprotection
性激素、心脏肥大细胞和心脏保护
  • 批准号:
    6774261
  • 财政年份:
    2004
  • 资助金额:
    $ 35.4万
  • 项目类别:
Sexual hormones, cardiac mast cells and cardioprotection
性激素、心脏肥大细胞和心脏保护
  • 批准号:
    7249503
  • 财政年份:
    2004
  • 资助金额:
    $ 35.4万
  • 项目类别:
Sexual hormones, cardiac mast cells and cardioprotection
性激素、心脏肥大细胞和心脏保护
  • 批准号:
    7283272
  • 财政年份:
    2004
  • 资助金额:
    $ 35.4万
  • 项目类别:
CARDIAC MAST CELL--ROLE IN PATHOGENESIS OF HEART FAILURE
心脏肥大细胞——在心力衰竭发病机制中的作用
  • 批准号:
    2824174
  • 财政年份:
    1999
  • 资助金额:
    $ 35.4万
  • 项目类别:
MYOCARDIAL INTEGRINS AND VENTRICULAR REMODELING
心肌整合素和心室重构
  • 批准号:
    6078843
  • 财政年份:
    1999
  • 资助金额:
    $ 35.4万
  • 项目类别:
CARDIAC MAST CELL--ROLE IN PATHOGENESIS OF HEART FAILURE
心脏肥大细胞——在心力衰竭发病机制中的作用
  • 批准号:
    6390263
  • 财政年份:
    1999
  • 资助金额:
    $ 35.4万
  • 项目类别:
CARDIAC MAST CELL--ROLE IN PATHOGENESIS OF HEART FAILURE
心脏肥大细胞——在心力衰竭发病机制中的作用
  • 批准号:
    6383280
  • 财政年份:
    1999
  • 资助金额:
    $ 35.4万
  • 项目类别:

相似海外基金

Larp6 and Alcoholic Cardiomyopathy
Larp6 和酒精性心肌病
  • 批准号:
    10683154
  • 财政年份:
    2022
  • 资助金额:
    $ 35.4万
  • 项目类别:
Dissecting the role of the cardiac fibroblast in hypertrophy.
剖析心脏成纤维细胞在肥厚中的作用。
  • 批准号:
    10667595
  • 财政年份:
    2022
  • 资助金额:
    $ 35.4万
  • 项目类别:
Atherosclerotic Risk of Branched Chain Amino Acids in a Tissue Engineered Blood Vessel Model
组织工程血管模型中支链氨基酸的动脉粥样硬化风险
  • 批准号:
    10536528
  • 财政年份:
    2022
  • 资助金额:
    $ 35.4万
  • 项目类别:
Mechanisms underlying myxomatous valve disease
粘液瘤性瓣膜疾病的机制
  • 批准号:
    10455614
  • 财政年份:
    2021
  • 资助金额:
    $ 35.4万
  • 项目类别:
Mechanisms underlying myxomatous valve disease
粘液瘤性瓣膜疾病的机制
  • 批准号:
    10312919
  • 财政年份:
    2021
  • 资助金额:
    $ 35.4万
  • 项目类别:
Mechanisms underlying myxomatous valve disease
粘液瘤性瓣膜疾病的机制
  • 批准号:
    10611524
  • 财政年份:
    2021
  • 资助金额:
    $ 35.4万
  • 项目类别:
The effect of systemic hypertension on prognosis of myocardial infarction: Understanding, prediction and therapy evaluation
全身性高血压对心肌梗死预后的影响:理解、预测和治疗评估
  • 批准号:
    10091577
  • 财政年份:
    2020
  • 资助金额:
    $ 35.4万
  • 项目类别:
Regulators of extracellular matrix production during cardiac development and disease
心脏发育和疾病过程中细胞外基质产生的调节因子
  • 批准号:
    10656462
  • 财政年份:
    2020
  • 资助金额:
    $ 35.4万
  • 项目类别:
The effect of systemic hypertension on prognosis of myocardial infarction: Understanding, prediction and therapy evaluation
全身性高血压对心肌梗死预后的影响:理解、预测和治疗评估
  • 批准号:
    10410363
  • 财政年份:
    2020
  • 资助金额:
    $ 35.4万
  • 项目类别:
Systems Mechanobiology Modeling for Patient-Specific Cardiac Fibrosis Predictions
用于患者特异性心脏纤维化预测的系统力学生物学建模
  • 批准号:
    10323449
  • 财政年份:
    2019
  • 资助金额:
    $ 35.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了